Thinking of joining a study?

Register your interest

Become a volunteer?

Clinical trials for Cancer in United States

7251 results

Sort By:

Feasibility and Safety of Collecting and Combining Autologous Hematopoietic Stem Cells With Chimeric Antigen Receptor (CAR) T-Cell Therapy in Subjects With Relapsed/Refractory Hematological Malignancies

Study ID: NCT05887167
Start Date: 2024-03-02
End Date: 2026-12-15
Study Type

Interventional

Study Phase

Phase1

No. of Participants

20

Intervention / Treatment

autologous hematopoietic stem cells added to planned CAR T

Sponsor

Joshua Sasine, MD, PhD

Source: clinicaltrials.gov

Share:
Add to list

Neurofibromatosis (NF) Registry Portal

Study ID: NCT01885767
Start Date: 2012-06
End Date: 2050-06
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

20000

Intervention / Treatment
Sponsor

The Children's Tumor Foundation

Source: clinicaltrials.gov

Share:
Add to list

Study of Novel Treatment Combinations in Patients With Lung Cancer

Study ID: NCT05633667
Start Date: 2023-03-16
End Date: 2027-01
Study Type

Interventional

Study Phase

Phase2

No. of Participants

593

Intervention / Treatment

ZIMITELIMAB (ZIM)

Domvanalimab (dom)

SATITUSUMAB Govitatan-Kziy (SG)

Etrumadenant (ETRuma)

Carboplatin

Cisplatin

Pemetrexed

Paclitaxel

Nab-paclitaxel

Docetaxel

Nivolumab

Sponsor

Gilead Sciences

Source: clinicaltrials.gov

Share:
Add to list

Intra-Operative Radiation Registry

Study ID: NCT04994067
Start Date: 2018-08-09
End Date: 2029-08
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

250

Intervention / Treatment
Sponsor

Albert Einstein College of Medicine

Source: clinicaltrials.gov

Share:
Add to list

Project CONTINUITY: Promoting Evidence-Based Cancer Screening Among Underserved Women

Study ID: NCT05390567
Start Date: 2024-06-07
End Date: 2025-05-01
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

800

Intervention / Treatment

Participant Choice of HPV Self-Test

Survey: Participant cancer history and cervical cancer prevention/screening knowledge

Participant Choice of Standard of Care in-clinic Pap-test

Sponsor

University of Florida

Source: clinicaltrials.gov

Share:
Add to list

A Study to Evaluate the Safety and Anti-cancer Activity of Loncastuximab Tesirine in Combination With Other Anti-cancer Agents in Participants With Relapsed or Refractory B-cell Non-Hodgkin Lymphoma (LOTIS-7)

Study ID: NCT04970901
Start Date: 2022-06-17
End Date: 2026-12-18
Study Type

Interventional

Study Phase

Phase1

No. of Participants

200

Intervention / Treatment

LONCASTUXİMAB influence

Polatuzumab Vedotin

Glofitamab

Mosunetuzumab

Obinutuzumab

Sponsor

ADC Therapeutics S.A.

Source: clinicaltrials.gov

Share:
Add to list

IS-free Treg HaploHCT

Study ID: NCT04678401
Start Date: 2021-01-12
End Date: 2027-12-31
Study Type

Interventional

Study Phase

Phase1

No. of Participants

20

Intervention / Treatment

Radiation

Fludarabine

Thiotepa

Cyclophosphamide

Meat

Treg-enriched donor cell

Unmodified donor T Cell

CD34+ Haplo Peripheral Blood Stem Cell

Sponsor

Dana-Farber Cancer Institute

Source: clinicaltrials.gov

Share:
Add to list

Biospecimen Procurement for Center for Immuno-Oncology Immunotherapy Protocols

Study ID: NCT02682667
Start Date: 2016-04-11
End Date: 2027-12-01
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

500

Intervention / Treatment
Sponsor

National Cancer Institute (NCI)

Source: clinicaltrials.gov

Share:
Add to list

Combination of TATE and PD-1 Inhibitor in Liver Cancer

Study ID: NCT03259867
Start Date: 2017-07-01
End Date: 2025-12-31
Study Type

Interventional

Study Phase

Phase2

No. of Participants

54

Intervention / Treatment

Nivolumab Injectable Product

Trans-arterial tirapazamine embolization

Sponsor

Teclison Ltd.

Source: clinicaltrials.gov

Share:
Add to list

LUNAR-2: TTFields With Pembrolizumab + Platinum-based Chemotherapy for Metastatic NSCLC

Study ID: NCT06216301
Start Date: 2024-07-31
End Date: 2028-10
Study Type

Interventional

Study Phase

Phase3

No. of Participants

734

Intervention / Treatment

NovoTTF-200T

Pembrolizumab

Platinum based chemotherapy

Sponsor

Novocure GMBH

Source: clinicaltrials.gov

Share:
Add to list